1Benabid AL, Koudsie A, Benazzouz A, et al.Deep brain stimulation of the corpus luysi ( subthalamic nucleus) and other targets in Parkinson' s disease. Extension to new indications such as dystonia and epilepsy. J Neurol,2001,248 Suppl 3 : Ⅲ37-47.
2Vingerhoets FJ, Villemure JG, Temperli P, et al. Subthalamic DBS replaces levodopa in Parkinson' s disease: two-year followup. Neurology, 2002, 58:396-401.
3Vitek JL. Mechanisms of deep brain stimulation: excitation or inhibition. Mov Disord, 2002, 17 Suppl 3: S69-72.
4Wichmann T, DeLong MR. Pathophysiology of Parkinson' s disease:the MPTP primate model of the human disorder. Ann N Y Acad Sci, 2003, 991:199-213.
5Li T, Thumen A, Moser A. Modulation of a neuronal network by electrical high frequency stimulation in striatal slices of the rat in vitro. Neurochem Int, 2006, 48:83-86.
6Paxions G, Waston C. The rat brain in stereotaxic coordinates. 25th ed. New York : Academic Press, 2007 : Ⅳ Ⅲ-Ⅸ Ⅹ Ⅱ.
7Heikkila RE, Shapiro BS, Duvoisin RC. The relationship between loss of dopamine nerve terminals, striatal [ 3 H ] spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine- lesioned rats. Brain Res,1981,211:285-292.
8Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanldininm thlocyanate-phenol-chloroform extraction. Anal Biochem, 1987, 162: 156-159.
9Papa SM, Auberson YP, Greenamyre JT. Prolongation of levodopa responses by glycineB antagonists in parkinsonian primates. Ann Neurol, 2004, 56:723-727.
10Anderson L, Caldwell MA. Human neural progenitor cell transplants into the subthalamic nucleus lead to functional recovery in a rat model of Parkinson' s disease. Neurobiol Dis,2007,27: 133-140.
